Sebenius, Isaac http://orcid.org/0000-0001-9927-2150
Seidlitz, Jakob http://orcid.org/0000-0002-8164-7476
Warrier, Varun http://orcid.org/0000-0003-4532-8571
Bethlehem, Richard A. I. http://orcid.org/0000-0002-0714-0685
Alexander-Bloch, Aaron http://orcid.org/0000-0001-6554-1893
Mallard, Travis T. http://orcid.org/0000-0002-3265-3001
Garcia, Rafael Romero http://orcid.org/0000-0002-5199-4573
Bullmore, Edward T. http://orcid.org/0000-0002-8955-8283
Morgan, Sarah E.
Article History
Received: 11 October 2022
Accepted: 8 June 2023
First Online: 17 July 2023
Competing interests
: E.T.B. works in an advisory role for Sosei Heptares, Boehringer Ingelheim, GlaxoSmithKline and Monument Therapeutics. A.A.B. receives consulting income from Octave Bioscience. The remaining authors declare no competing interests.